Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

That is an impressive deal. So isn't the Galapagos brain trust, both in terms of management and directors.

From the Galagopos website, "The Galapagos group, including fee-for-service subsidiairy Fidelta, has approximately 700 employees, operating from its Mechelen, Belgium headquarters and facilities in The Netherlands, France, Switzerland, the US and Croatia."

Also, from their website (a 4/25/19 pr):Bart Filius, COO & CFO, added: "While expanding our early stage clinical portfolio and executing clinical trials on the later stage assets, we incurred an operational cash burn[1] of €76.3 million in the first quarter. Given the expected growth in development activity this year, we retain our full year 2019 cash burn guidance of €320-340 million. Our current total cash and cash equivalents position is approximately €1.2 billion, maintaining an excellent financial position to deliver the trials and earlier R&D research planned."

Galapogas is clearly highly respected in their field.